Generics Market in Brazil Is Booming
According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", the Brazil pharmaceutical industry has been witnessing higher growth in Generics drug production owing to Government support and patent expiries of various blockbuster drugs. In 2013, Generic drugs accounted for 26% of the pharmaceutical market in Brazil, generating approximately US$ 7.0 Billion revenue. With a price at least 35% cheaper than brand name drugs and several Brazilian companies operating in the sector, generic manufacturing has been...
View full press release